Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity
Antje Arnold(Johns Hopkins University), Eric H. Raabe(Johns Hopkins University), Charles G. Eberhart(Johns Hopkins University), Ming Yuan(Heilongjiang Provincial Academy of Agricultural Sciences), Lauren Harris(Brigham and Women's Hospital), Antionette Price(Johns Hopkins University)
Cited by 36
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711